Meyka Pro banner
AIxCrypto Holdings, Inc.

AIxCrypto Holdings, Inc. (NASDAQ: AIXC) Stock Competitors & Peer Comparison

See AIXC's competitors and their performance on the NASDAQ and across the wider stock market.

AIXCNASDAQ
HealthcareMedical - Pharmaceuticals
$0.79
$0.05(5.47%)
U.S. Market opens in 12h 39m

Peer Comparison Table: Medical - Pharmaceuticals Industry

Detailed financial metrics including price, market cap, P/E ratio, and more for AIXC and its NASDAQ peers.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
AIXC$0.79-5.47%4.1M-0.09-$9.17N/A
RPRX$57.97+2.11%25.7B11.04$5.25+1.58%
CORT$114.23+3.12%12.3B326.37$0.35N/A
WBA$11.98+0.50%10.4B-1.64-$7.29+4.17%
LQDA$91.03+0.90%8.1B650.21$0.14N/A
KNSA$76.53+0.62%5.8B85.03$0.90N/A
TRLV$9.08+3.77%1.5B-21.50-$0.42N/A
HROWL$25.61+0.19%1.4BN/AN/AN/A
HROWM$26.03-0.08%1.3BN/AN/AN/A
LTGO$18.56+1.70%1.1BN/AN/AN/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

Royalty Pharma plc (NASDAQ: RPRX)

AIXC vs RPRX Comparison August 2026

AIxCrypto Holdings, Inc. (NASDAQ: AIXC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, AIXC stands at 4.1M. In comparison, RPRX has a market cap of 25.7B. Regarding current trading prices, AIXC is priced at $0.79 on the NASDAQ, while RPRX trades at $57.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

AIXC currently has a P/E ratio of -0.09, whereas RPRX's P/E ratio is 11.04. In terms of profitability, AIXC's ROE is -0.94%, compared to RPRX's ROE of +0.12%. Regarding short-term risk, AIXC is more volatile compared to RPRX. This indicates higher risk in terms of short-term price fluctuations for AIXC.Check RPRX's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions